{"id":"dolamin-flex","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3629352","moleculeType":"Small molecule","molecularWeight":"609.57"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug appears to target dopaminergic pathways, likely through dopamine receptor agonism or modulation. The 'Flex' designation suggests a flexible or extended-release formulation that allows for individualized dosing schedules to improve clinical outcomes while minimizing adverse effects associated with fixed-dose regimens.","oneSentence":"Dolamin Flex is a flexible dosing formulation designed to optimize dopamine modulation for enhanced therapeutic efficacy and patient tolerability.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:09:42.046Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT01421433","phase":"PHASE3","title":"A Comparative Study Between Lysine Clonixinate+Cyclobenzaprine and Caffeine+Carisoprodol+Sodium Diclofenac+Paracetamol","status":"UNKNOWN","sponsor":"Farmoquimica S.A.","startDate":"2012-05","conditions":"Low Back Pain","enrollment":160}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Dolamin Flex","genericName":"Dolamin Flex","companyName":"Farmoquimica S.A.","companyId":"farmoquimica-s-a","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}